Mark P. Colonnese
2016 - Biota Pharmaceuticals
In 2016, Mark P. Colonnese earned a total compensation of $749.9K as Executive Vice President and Chief Financial Officer at Biota Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $48,400 |
|---|---|
| Option Awards | $291,713 |
| Salary | $233,750 |
| Other | $176,082 |
| Total | $749,945 |
Colonnese received $291.7K in option awards, accounting for 39% of the total pay in 2016.
Colonnese also received $48.4K in non-equity incentive plan, $233.8K in salary and $176.1K in other compensation.
Rankings
In 2016, Mark P. Colonnese's compensation ranked 9,573rd out of 14,075 executives tracked by ExecPay. In other words, Colonnese earned more than 32.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,573 out of 14,075 | 32nd |
Division Manufacturing | 3,707 out of 5,488 | 33rd |
Major group Chemicals And Allied Products | 1,290 out of 1,900 | 32nd |
Industry group Drugs | 1,026 out of 1,543 | 34th |
Industry Biological Products, Except Diagnostic Substances | 179 out of 287 | 38th |
Source: SEC filing on September 27, 2016.
Colonnese's colleagues
We found two more compensation records of executives who worked with Mark P. Colonnese at Biota Pharmaceuticals in 2016.